LouiseVan Der Weerd
PhD
Location
Leiden, The Netherlands
Current Organization
Leiden University Medical Center
Biography
Dr. Louise van der Weerd holds an MSc and PhD in Biophysics from Wageningen University in the Netherlands and gained post-doctoral experience in neuroscience at University College London, United Kingdom. She joined the Leiden University Medical Center in The Netherlands 2005, Where she is now an associate professor and director of the pre-clinical imaging facility. The VanderWeerd lab is integrated within the departments of Radiology and Human Genetics, securing a smooth integration of the imaging work with pathophysiological validation on animal and cell models, as well as human tissue. Her research revolves around the use and development of novel MRI and other pre-clinical imaging techniques to characterize neurological and cardiovascular disease processes. Dr. Van der Weerd is a partner or work package leader in several national and European consortia focusing on imaging in Alzheimer’s Disease and CAA and neurovascular function in general, with a strong focus on post-mortem and in vivo brain imaging as evidenced from several grants awarded for post-mortem imaging in various neurodegenerative diseases. She also was awarded several prestigious personal awards (VENI and VIDI) on this topic. As such, she has ample experience with international consortia, and maintains fruitful collaborations globally, as evidenced by >100 peer-reviewed publications.
Grants
Grants Featuring
Louise Van Der Weerd, PhD
Alzheimer's Disease Research
Iron Spreading Patterns in Alzheimer's Disease
Active Dates
July 01, 2023 - June 30, 2026
Principal Investigator
Louise Van Der Weerd, PhD
Iron Spreading Patterns in Alzheimer's Disease
Active Dates
July 01, 2023 - June 30, 2026
Principal Investigator
Louise Van Der Weerd, PhD
Alzheimer's Disease Research
Detecting Leaky Vessels in Cerebral Amyloid Angiopathy
Active Dates
January 01, 2022 - June 30, 2025
Principal Investigator
Whitney Freeze, PhD
Detecting Leaky Vessels in Cerebral Amyloid Angiopathy
Active Dates
January 01, 2022 - June 30, 2025
Principal Investigator
Whitney Freeze, PhD